Get the Stockscreener App
5.88
121.05%
3.22
After Hours:
5.32
-0.56
-9.52%
Pepgen Inc stock is traded at $5.88, with a volume of 124.59M.
It is up +121.05% in the last 24 hours and up +348.85% over the past month.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
See More
Previous Close:
$2.66
Open:
$5.9
24h Volume:
124.59M
Relative Volume:
53.22
Market Cap:
$192.86M
Revenue:
-
Net Income/Loss:
$-87.23M
P/E Ratio:
-1.9798
EPS:
-2.97
Net Cash Flow:
$-82.77M
1W Performance:
+186.83%
1M Performance:
+348.85%
6M Performance:
+289.40%
1Y Performance:
-31.71%
1-Day Range:
$4.90
$6.34
1-Week Range:
$1.82
$6.34
52-Week Range:
$0.8801
$9.935
Pepgen Inc Stock (PEPG) Company Profile
Name
Pepgen Inc
Sector
Industry
Phone
703-456-8000
Address
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
5.88 | 87.25M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-25 | Initiated | Guggenheim | Buy |
| Dec-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-21-22 | Initiated | H.C. Wainwright | Buy |
Pepgen Inc Stock (PEPG) Latest News
PepGen Inc. (PEPG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Form 424B5 PepGen Inc. - StreetInsider
PepGen, Inc. (NASDAQ:PEPG) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
PepGen stock price target raised to $12 from $8 at H.C. Wainwright - Investing.com India
PepGen (NASDAQ:PEPG) Given New $12.00 Price Target at Stifel Nicolaus - MarketBeat
S&P 500 Falls 1%; Accenture Posts Upbeat Earnings - Benzinga
Top Biotech Stocks To Watch TodaySeptember 25th - MarketBeat
Biotech Small Caps Catch Fire On Clinical And Tech News - Finimize
PepGen Stock Skyrockets Over 110% on Breakthrough DM1 Trial Results - Tokenist
Surge in PepGen Stock: What Investors Need to Know - timothysykes.com
Why Is PepGen Stock (PEPG) Up 125% Today? - TipRanks
Unusually active option classes on open September 25th - TipRanks
Is PepGen the Next Big Investment? - StocksToTrade
PepGen (PEPG) Stock: Biotech Surges 145% on Record DM1 Treatment Results - parameter.io
Why Is PepGen Stock Soaring On ThursdayPepGen (NASDAQ:PEPG) - Benzinga
Wedbush Forecasts Strong Price Appreciation for PepGen (NASDAQ:PEPG) Stock - MarketBeat
PepGen price target raised to $9 from $7 at Wedbush - TipRanks
Stocks Moving Premarket: PEPG, WOK, ICU, And Other Gainers & Losers - RTTNews
PepGen (NASDAQ:PEPG) Price Target Raised to $12.00 at HC Wainwright - MarketBeat
PepGen price target raised to $12 from $8 at H.C. Wainwright - TipRanks
PepGen stock soars after reporting highest splicing correction in DM1 patients - Investing.com Canada
PepGen announces public offering of common stock and pre-funded warrants - Investing.com Nigeria
Why PepGen Shares Are Trading Higher By 112%; Here Are 20 Stocks Moving Premarket - Benzinga
PepGen shares more than double after muscle disease drug shows promise in trial - TradingView
PepGen Inc. Announces Positive Phase 1 Study Results - TipRanks
PepGen Prices $100 Million Stock Offering; Shares Soar Pre-Bell - MarketScreener
PepGen (PEPG) Launches $100M Stock Offering to Fund Clinical Trials - GuruFocus
IMRX Soars On Pancreatic Cancer Data, PEPG Sets DM1 Splicing Correction Record, CLPT On Watch - RTTNews
PepGen Announces Pricing of $100 Million Public Offering - BioSpace
PepGen prices common stock offering at $3.20 per share to raise $100m - Investing.com
PepGen prices 31 million shares at $3.20 per share - MarketScreener
PepGen reports positive DM1 treatment data with 53.7% splicing correction By Investing.com - Investing.com Australia
PepGen (PEPG) Stock: Soars 119% Following Major Public Offering Proposal - parameter.io
PepGen Reports Highest Mean Splicing Correction in Myotonic Dystrophy Trial; Shares Jump After Hours - MarketScreener
PepGen reports positive DM1 treatment data with 53.7% splicing correction - Investing.com India
PepGen announces common stock offering, no amount given - TipRanks
PepGen says FREEDOM clinical study achieves all key objectives - TipRanks
PepGen Announces Proposed Public Offering - Business Wire
PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients - Business Wire
PepGen's (PEPG) Buy Rating Reiterated at Guggenheim - MarketBeat
Is PepGen Inc. reversing from oversold territory2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
Is PepGen Inc. still worth holding after the dipTrade Risk Assessment & High Conviction Buy Zone Alerts - newser.com
Is PepGen Inc. stock poised for growth2025 Market Outlook & Real-Time Market Trend Scan - newser.com
Can trapped investors hope for a rebound in PepGen Inc.Portfolio Value Report & AI Enhanced Trading Alerts - newser.com
What data driven models say about PepGen Inc.’s futureQuarterly Investment Review & Low Drawdown Momentum Ideas - newser.com
Using Bollinger Bands to evaluate PepGen Inc.Quarterly Portfolio Review & Risk Managed Investment Strategies - newser.com
Is PepGen Inc. trending in predictive chart modelsEarnings Trend Report & Stepwise Entry and Exit Trade Signals - newser.com
Can PepGen (NASDAQ:PEPG) Afford To Invest In Growth? - Yahoo Finance
Applying sector rotation models to PepGen Inc.Earnings Miss & Smart Money Movement Tracker - newser.com
Pepgen Inc Stock (PEPG) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):